BHMT and MTHFD1 variants increase folate demand and can raise homocysteine when folate is low.

Genetic variants in the BHMT and MTHFD1 enzymes significantly alter the efficiency of one-carbon metabolism, creating a heightened physiological requirement for folate to maintain metabolic balance and manage homocysteine levels.

Mechanistic explanations

One-carbon metabolism relies on two primary pathways to remethylate homocysteine into methionine: the folate-dependent pathway and the folate-independent (betaine-dependent) pathway.

• MTHFD1 Function: The MTHFD1 enzyme is a trifunctional protein essential for partitioning one-carbon units. The common G1958A (rs2236225) variant destabilizes the enzyme and reduces the availability of 5,10-methylene-tetrahydrofolate. This deficit shifts metabolic flux away from DNA synthesis and toward homocysteine remethylation, directly increasing the cellular demand for folate to compensate for the reduced enzyme efficiency.
• BHMT Pathway Shifts: Betaine-homocysteine S-methyltransferase (BHMT) provides an alternative, folate-independent route for homocysteine clearance using betaine. Variants like BHMT G742A (rs3733890) can impair this bypass. When this pathway is less efficient, the body compensates by increasing its reliance on the folate-dependent MTHFR/MTR pathway. This shift effectively "borrows" folate capacity, further elevating the dietary or supplemental folate intake required to prevent homocysteine accumulation.

Clinical evidence and implications

The interaction between these genetic predispositions and nutritional status is a primary determinant of homocysteine concentrations.

• Increased Folate Demand: Research suggests that individuals with these genetic variants may require 2 to 5 times higher folate intake than the general population to normalize metabolic flux.
• Homocysteine Elevation: Low serum folate is a dominant predictor of hyperhomocysteinemia (homocysteine >15 µmol/L). In the presence of BHMT or MTHFD1 variants, the sensitivity to folate deficiency is amplified; even moderate folate insufficiency can lead to significantly higher homocysteine levels compared to wild-type individuals, as the alternative clearance pathways are simultaneously compromised.

Bottom line

Genetic variants in BHMT and MTHFD1 increase reliance on folate-dependent pathways by impairing alternative remethylation routes and destabilizing key enzymes. For carriers, maintaining high-normal serum folate levels is critical to offset this increased demand and prevent elevated homocysteine.